Harris Todd 4
4 · Tyra Biosciences, Inc. · Filed Sep 25, 2024
Insider Transaction Report
Form 4
Harris Todd
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-09-23$24.13/sh−10,092$243,477→ 1,479,528 total - Sale
Common Stock
2024-09-25$24.01/sh−600$14,406→ 1,477,873 total - Sale
Common Stock
2024-09-24$24.02/sh−1,055$25,341→ 1,478,473 total
Footnotes (4)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.005 to $24.25. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.00 to $24.14. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F4]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.00 to $24.06. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.